Cargando…

Identification of cancer driver genes based on nucleotide context

Cancer genomes contain large numbers of somatic mutations, but few of these mutations drive tumor development. Current approaches identify driver genes based on mutational recurrence, or they approximate the functional consequences of nonsynonymous mutations using bioinformatic scores. While passeng...

Descripción completa

Detalles Bibliográficos
Autores principales: Dietlein, Felix, Weghorn, Donate, Taylor-Weiner, Amaro, Richters, André, Reardon, Brendan, Liu, David, Lander, Eric S., Van Allen, Eliezer M., Sunyaev, Shamil R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031046/
https://www.ncbi.nlm.nih.gov/pubmed/32015527
http://dx.doi.org/10.1038/s41588-019-0572-y
_version_ 1783499291013152768
author Dietlein, Felix
Weghorn, Donate
Taylor-Weiner, Amaro
Richters, André
Reardon, Brendan
Liu, David
Lander, Eric S.
Van Allen, Eliezer M.
Sunyaev, Shamil R.
author_facet Dietlein, Felix
Weghorn, Donate
Taylor-Weiner, Amaro
Richters, André
Reardon, Brendan
Liu, David
Lander, Eric S.
Van Allen, Eliezer M.
Sunyaev, Shamil R.
author_sort Dietlein, Felix
collection PubMed
description Cancer genomes contain large numbers of somatic mutations, but few of these mutations drive tumor development. Current approaches identify driver genes based on mutational recurrence, or they approximate the functional consequences of nonsynonymous mutations using bioinformatic scores. While passenger mutations are enriched in characteristic nucleotide contexts, driver mutations occur in functional positions, which are not necessarily surrounded by a particular nucleotide context. We observed that mutations in contexts that deviate from the characteristic contexts around passenger mutations provide a signal in favor of driver genes. We therefore developed a method that combines this feature with the signals traditionally used for driver gene identification. We applied our method to whole-exome sequencing data from 11,873 tumor-normal pairs and identified 460 driver genes that clustered into 21 cancer-related pathways. Our study provides a resource of driver genes across 28 tumor types with additional driver genes identified based on mutations in unusual nucleotide contexts.
format Online
Article
Text
id pubmed-7031046
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-70310462020-08-03 Identification of cancer driver genes based on nucleotide context Dietlein, Felix Weghorn, Donate Taylor-Weiner, Amaro Richters, André Reardon, Brendan Liu, David Lander, Eric S. Van Allen, Eliezer M. Sunyaev, Shamil R. Nat Genet Article Cancer genomes contain large numbers of somatic mutations, but few of these mutations drive tumor development. Current approaches identify driver genes based on mutational recurrence, or they approximate the functional consequences of nonsynonymous mutations using bioinformatic scores. While passenger mutations are enriched in characteristic nucleotide contexts, driver mutations occur in functional positions, which are not necessarily surrounded by a particular nucleotide context. We observed that mutations in contexts that deviate from the characteristic contexts around passenger mutations provide a signal in favor of driver genes. We therefore developed a method that combines this feature with the signals traditionally used for driver gene identification. We applied our method to whole-exome sequencing data from 11,873 tumor-normal pairs and identified 460 driver genes that clustered into 21 cancer-related pathways. Our study provides a resource of driver genes across 28 tumor types with additional driver genes identified based on mutations in unusual nucleotide contexts. 2020-02-03 2020-02 /pmc/articles/PMC7031046/ /pubmed/32015527 http://dx.doi.org/10.1038/s41588-019-0572-y Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Dietlein, Felix
Weghorn, Donate
Taylor-Weiner, Amaro
Richters, André
Reardon, Brendan
Liu, David
Lander, Eric S.
Van Allen, Eliezer M.
Sunyaev, Shamil R.
Identification of cancer driver genes based on nucleotide context
title Identification of cancer driver genes based on nucleotide context
title_full Identification of cancer driver genes based on nucleotide context
title_fullStr Identification of cancer driver genes based on nucleotide context
title_full_unstemmed Identification of cancer driver genes based on nucleotide context
title_short Identification of cancer driver genes based on nucleotide context
title_sort identification of cancer driver genes based on nucleotide context
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031046/
https://www.ncbi.nlm.nih.gov/pubmed/32015527
http://dx.doi.org/10.1038/s41588-019-0572-y
work_keys_str_mv AT dietleinfelix identificationofcancerdrivergenesbasedonnucleotidecontext
AT weghorndonate identificationofcancerdrivergenesbasedonnucleotidecontext
AT taylorweineramaro identificationofcancerdrivergenesbasedonnucleotidecontext
AT richtersandre identificationofcancerdrivergenesbasedonnucleotidecontext
AT reardonbrendan identificationofcancerdrivergenesbasedonnucleotidecontext
AT liudavid identificationofcancerdrivergenesbasedonnucleotidecontext
AT landererics identificationofcancerdrivergenesbasedonnucleotidecontext
AT vanalleneliezerm identificationofcancerdrivergenesbasedonnucleotidecontext
AT sunyaevshamilr identificationofcancerdrivergenesbasedonnucleotidecontext